12.67
price up icon0.88%   0.11
after-market After Hours: 12.67
loading
Elanco Animal Health Inc stock is traded at $12.67, with a volume of 2.88M. It is up +0.88% in the last 24 hours and down -13.57% over the past month. Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$12.56
Open:
$12.45
24h Volume:
2.88M
Relative Volume:
0.64
Market Cap:
$6.26B
Revenue:
$4.49B
Net Income/Loss:
$-1.26B
P/E Ratio:
-63.35
EPS:
-0.2
Net Cash Flow:
$425.00M
1W Performance:
+1.28%
1M Performance:
-13.57%
6M Performance:
-6.36%
1Y Performance:
+31.84%
1-Day Range:
Value
$12.35
$12.77
1-Week Range:
Value
$12.35
$12.83
52-Week Range:
Value
$9.26
$18.80

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
Name
Elanco Animal Health Inc
Name
Phone
877-352-6261
Name
Address
2500 INNOVATION WAY, GREENFIELD
Name
Employee
9,800
Name
Twitter
@Elanco
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ELAN's Discussions on Twitter

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-05-24 Upgrade Stifel Hold → Buy
Dec-19-23 Initiated Jefferies Buy
Dec-15-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-07-23 Initiated Exane BNP Paribas Outperform
Apr-20-23 Upgrade Barclays Equal Weight → Overweight
Aug-18-22 Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-16-22 Downgrade JP Morgan Overweight → Neutral
Jul-21-22 Downgrade Goldman Buy → Sell
Jul-12-22 Initiated Piper Sandler Neutral
Nov-18-21 Initiated Morgan Stanley Overweight
Oct-28-21 Downgrade Stifel Buy → Hold
Aug-05-21 Resumed Credit Suisse Outperform
Jun-15-21 Upgrade Cleveland Research Underperform → Neutral
May-11-21 Upgrade Barclays Underweight → Equal Weight
May-11-21 Upgrade Gabelli & Co Hold → Buy
Apr-15-21 Initiated Stifel Buy
Mar-22-21 Downgrade Gabelli & Co Buy → Hold
Feb-26-21 Upgrade Credit Suisse Neutral → Outperform
Dec-09-20 Downgrade Argus Buy → Hold
Nov-09-20 Downgrade Barclays Overweight → Underweight
Aug-20-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Aug-13-20 Resumed Credit Suisse Neutral
Aug-04-20 Resumed Goldman Buy
Jul-27-20 Downgrade Cleveland Research Neutral → Underperform
Apr-02-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-10-20 Initiated Raymond James Mkt Perform
Dec-19-19 Upgrade BofA/Merrill Neutral → Buy
Nov-07-19 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-23-19 Initiated Barclays Overweight
Aug-26-19 Downgrade BofA/Merrill Buy → Neutral
Aug-15-19 Upgrade UBS Sell → Neutral
May-23-19 Initiated Guggenheim Neutral
Mar-18-19 Upgrade BofA/Merrill Neutral → Buy
Mar-13-19 Resumed Morgan Stanley Equal-Weight
Feb-12-19 Initiated William Blair Mkt Perform
Jan-23-19 Initiated UBS Sell
Jan-15-19 Initiated Argus Buy
Oct-15-18 Initiated Morgan Stanley Equal-Weight
View All

Elanco Animal Health Inc Stock (ELAN) Latest News

pulisher
08:10 AM

Pet Medication Market: Comprehensive Analysis and Key Players-Zoetis, Merck, Merial, Elanco, Bayer. - openPR

08:10 AM
pulisher
07:08 AM

ELAN LAWSUIT ALERT: BFA Law Announces Elanco Animal Health has been Sued for Securities Fraud and Urges Investors to Contact the Firm by December 6 Deadline - Newsfile

07:08 AM
pulisher
05:45 AM

Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - PR Newswire

05:45 AM
pulisher
Nov 04, 2024

The Gross Law Firm Notifies Elanco Animal Health Incorporated In - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile– Hagens Berman - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile– Hagens Berman - GlobeNewswire Inc.

Nov 04, 2024
pulisher
Nov 04, 2024

Elanco Animal Health (ELAN) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

ELAN LAWSUIT ALERT: A Securities Fraud Class Action has - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

2024-11-04 | ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing

Nov 04, 2024
pulisher
Nov 04, 2024

Class Action Filed Against Elanco Animal Health Incorporated (ELAN) Seeking Recovery for InvestorsContact The Gross Law Firm - PR Newswire

Nov 04, 2024
pulisher
Nov 04, 2024

Animal Parasiticides Market Anticipated for Positive Growth - openPR

Nov 04, 2024
pulisher
Nov 03, 2024

ROSEN, LEADING INVESTOR COUNSEL, Encourages Elanco Animal - GlobeNewswire

Nov 03, 2024
pulisher
Nov 03, 2024

ROSEN, LEADING INVESTOR COUNSEL, Encourages Elanco Animal Health Incorporated Investors to - The Bakersfield Californian

Nov 03, 2024
pulisher
Nov 03, 2024

US FDA approves Elanco's treatment for parasitic infections in dogs - AOL

Nov 03, 2024
pulisher
Nov 03, 2024

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elanco Animal Health - PR Newswire

Nov 03, 2024
pulisher
Nov 03, 2024

Elanco Animal Health Incorporated (NYSE:ELAN) Position Increased by Harbor Capital Advisors Inc. - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

2024-11-03 | ELAN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NYSE:ELAN | Press Release - Stockhouse Publishing

Nov 03, 2024
pulisher
Nov 02, 2024

ELAN Investors Have Opportunity to Lead Elanco Animal Health Inc - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Elanco Animal Health Incorporated of Class Action Lawsuit and Upcoming DeadlinesELAN - PR Newswire

Nov 02, 2024
pulisher
Nov 02, 2024

Private Management Group Inc. Increases Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Nov 02, 2024
pulisher
Nov 02, 2024

ELAN (Elanco Animal Health) Cyclically Adjusted FCF per Sha - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

ELAN (Elanco Animal Health) Other Current Assets : $904 Mil (As of Jun. 2024) - GuruFocus.com

Nov 02, 2024
pulisher
Nov 02, 2024

ELANCO ANIMAL HEALTH has been Sued for Securities Fraud - GlobeNewswire

Nov 02, 2024
pulisher
Nov 01, 2024

ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Lawsuit - PR Newswire

Nov 01, 2024
pulisher
Nov 01, 2024

Elanco Animal Health Incorporated Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationELAN - PR Newswire

Nov 01, 2024
pulisher
Oct 31, 2024

Elanco (ELAN) Faces Federal Lawsuit Over Alleged Misrepresentation of Zenrelia's Safety Profile – Hagens Berman - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

ELAN CLASS ACTION: Elanco Animal Health Investors with - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Elanco Animal Health Incorporated (ELAN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

The Gross Law Firm Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - PR Newswire

Oct 31, 2024
pulisher
Oct 31, 2024

Raymond James & Associates Sells 777,405 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

Levi & Korsinsky Reminds Elanco Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 6, 2024ELAN - PR Newswire

Oct 29, 2024
pulisher
Oct 29, 2024

ELAN DEADLINE NOTICE: Elanco Animal Health Investors are - GlobeNewswire

Oct 29, 2024
pulisher
Oct 28, 2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Oct 28, 2024
pulisher
Oct 28, 2024

White River State Park announces a 15-acre waterfront expansion - INDYtoday

Oct 28, 2024
pulisher
Oct 28, 2024

Action Alert: Elanco Securities Class Action Deadline Approaches - CEO Today

Oct 28, 2024
pulisher
Oct 28, 2024

White River State Park reveals plans for $65M expansion on stamping plant site - Daily Journal

Oct 28, 2024
pulisher
Oct 28, 2024

ELAN Investors Have Opportunity to Lead Elanco Animal Health Incorporated Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

Oct 28, 2024
pulisher
Oct 28, 2024

Elanco Animal Health (NYSE:ELAN) Price Target Cut to $19.00 - MarketBeat

Oct 28, 2024
pulisher
Oct 28, 2024

Europe Companion Animal Health Market Report Analysis - openPR

Oct 28, 2024
pulisher
Oct 28, 2024

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 6, 2024 in Elanco LawsuitELAN - PR Newswire

Oct 28, 2024
pulisher
Oct 28, 2024

ELAN FRAUD ALERT: BFA Law Notifies Elanco Animal Health - GlobeNewswire

Oct 28, 2024
pulisher
Oct 27, 2024

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elanco - GlobeNewswire

Oct 27, 2024

Elanco Animal Health Inc Stock (ELAN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$114.96
price down icon 0.42%
$89.24
price up icon 3.56%
$58.48
price down icon 0.36%
$121.53
price up icon 0.83%
$11.61
price up icon 1.40%
Cap:     |  Volume (24h):